CIML NK Cells

· Dana-Farber Cancer Institute

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CIML NK Cells, covering 2026-01-02 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: CIML NK Cells With Venetoclax for AML [Phase 1]